 |
Previous Article | Next Article 
The Journal of Neuroscience, November 1, 2000, 20(21):7888-7895
Reduction in the Density and Expression, But Not G-Protein
Coupling, of Serotonin Receptors (5-HT1A) in 5-HT
Transporter Knock-Out Mice: Gender and Brain Region Differences
Qian
Li1,
Christine
Wichems1,
Armin
Heils1,
Klaus-Peter
Lesch2, and
Dennis L.
Murphy1
1 Laboratory of Clinical Science, National Institute of
Mental Health, National Institutes of Health Clinical Center, Bethesda,
Maryland 20892-1264, and 2 Department of Psychiatry,
University of Würzburg, 97080 Würzburg, Germany
 |
ABSTRACT |
The aim of the present study was to investigate the mechanisms
underlying the desensitization of 5-HT1A receptors in the
dorsal raphe and hypothalamus of serotonin (5-HT) transporter knock-out mice (5-HTT / ). The density of 5-HT1A receptors in the
dorsal raphe was reduced in both male and female 5-HTT / mice. This reduction was more extensive in female than in male 5-HTT / mice.
8-OH-DPAT-induced hypothermia was absent in female 5-HTT / and
markedly attenuated in 5-HTT +/ mice. The density of 5-HT1A receptors also was decreased significantly in
several nuclei of the hypothalamus, amygdala, and septum of female
5-HTT / mice. 5-HT1A receptor mRNA was reduced
significantly in the dorsal raphe region, but not in the
hypothalamus or hippocampus, of female 5-HTT +/ and 5-HTT
/ mice. G-protein coupling to 5-HT1A receptors and G-protein levels in most brain regions were not reduced
significantly, except that Go and Gi1 proteins
were reduced modestly in the midbrain of 5-HTT / mice. These data
suggest that the desensitization of 5-HT1A receptors in
5-HTT / mice may be attributable to a reduction in the density of
5-HT1A receptors. This reduction is brain region-specific
and more extensive in the female mice. The reduction in the density of
5-HT1A receptors may be mediated partly by reduction in the
gene expression of 5-HT1A receptors in the dorsal raphe,
but also by other mechanisms in the hypothalamus of 5-HTT / female
mice. Finally, alterations in G-protein coupling to 5-HT1A
receptors are unlikely to be involved in the desensitization of
5-HT1A receptors in 5-HTT / mice.
Key words:
5-HT1A receptors; 5-HT1A mRNA; 5-HT transporter knock-out mice; G-protein coupling; hypothermia; gender difference; autoradiography; competitive RT-PCR; in situ
hybridization
 |
INTRODUCTION |
Increasing evidence suggests that
the function of serotonin (5-HT) transporter is important in the
regulation of emotional states. For example, polymorphisms in the 5'
regulatory region and intron 2 of the 5-HT transporter (5-HTT) gene,
which affects 5-HTT expression, may be related to neuroticism and some
affective disorders (Lesch et al., 1996 ; Mazzanti et al., 1998 ;
MacKenzie and Quinn, 1999 ; Greenberg et al., 2000 ; Stoltenberg and
Burmeister, 2000 ). Also, the 5-HTT is the target of a widely used class
of antidepressant drugs: the selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine (Prozac). The 5-HTT removes released 5-HT
from serotonergic nerve terminals and along axons (Zhou et al., 1998 ).
In doing so, the 5-HTT terminates the activation of postsynaptic 5-HT
receptors by extracellular 5-HT. It is believed that the effects of
5-HTT on the regulation of emotion are mediated by adaptive changes in
the serotonergic system induced by alterations in extracellular 5-HT
concentration. Therefore, studying the mechanisms underlying the
effects of 5-HTT on emotion will have a significant impact on our
understanding of the etiology of psychiatric disorders and should help
to develop better therapeutic approaches for psychiatric disorders.
5-HT1A receptors play a role in anxiety and
probably also in depression. Previous studies showed that disruption of
5-HTT function either by chronic SSRIs or by knock-out of the 5-HTT gene produces a desensitization (decrease in physiological responses to
the stimulation of 5-HT1A receptors) of
5-HT1A receptors in the hypothalamus and dorsal
raphe nucleus (Le Poul et al., 1995 ; Li et al., 1996 , 1997a , 1999 ;
Blier et al., 1998 ). Behaviorally, 5-HTT knock-out mice (5-HTT /
mice) are more anxious relative to 5-HTT +/+ mice (as examined by the
elevated zero maze and light/dark box) (Murphy et al., 1999 ; C. Wichems, unpublished data). Interestingly, these behavioral alterations
also are observed in 5-HT1A receptor knock-out
mice (Heisler et al., 1998 ; Parks et al., 1998 ; Ramboz et al., 1998 ;
Zhuang et al., 1999 ). These results suggest that desensitization of
5-HT1A receptors may play an important role in
the effects of 5-HTT on emotion. In fact, several clinical studies have
reported that the combined administration of
5-HT1A antagonists with SSRIs produces an earlier
therapeutic effect than SSRIs alone, suggesting that desensitization of
5-HT1A receptors may contribute to the
therapeutic effects of SSRIs. Therefore, studying the mechanisms
underlying the desensitization of 5-HT1A receptors induced by disruption of the function of 5-HTT should help us
to understand the effects of 5-HTT on the regulation of emotion.
The purpose of the present study was to investigate the mechanisms
underlying the desensitization of 5-HT1A
receptors in 5-HTT mutant mice. Because the desensitization of
5-HT1A receptors can be attributable to reduction
in the density or the G-protein coupling to
5-HT1A receptors, we examined the density of
5-HT1A receptors, their mRNA, and G-protein
coupling. To determine whether the desensitization of
5-HT1A receptors is mediated by a decrease in the
concentration of G-proteins that are coupled with
5-HT1A receptors, we also examined several
G-proteins in various brain regions.
 |
MATERIALS AND METHODS |
Animals
5-HTT mutant mice from a CD-1x129sv/ev background were created
by homologous recombination as previously reported (Bengel et al.,
1998 ). The 5-HTT mutant mice were from the F5 generation of backcross
mating with CD1 mice and were 3-5 months of age, with body weights of
30-40 gm. The mice were housed in groups of four to five per cage in a
light- (12 hr light/dark, lights on at 6 A.M.), humidity-, and
temperature-controlled room. Food and water were available ad
libitum. In all of the experiments, five to eight male or female
mice, as noted, were included in each group. All animal procedures were
approved by the National Institute of Mental Health Animal Care and Use Committee.
 |
Materials |
(+)8-OH-DPAT and (±)8-OH-DPAT
[8-hydroxy-2-(di-n-propylamino)tetraline] were
purchased from Research Biochemicals International (RBI, Natick, MA).
125I-MPPI
[4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridinyl-)-iodo-benzamido]ethyl]piperazine] and 35S-GTP- -S were purchased from NEN
Life Science Products (Boston, MA). Antibodies for
Go and Gz proteins were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
Anti-Gi1/2 serum, AS7, was purchased from NEN
Life Science Products. Anti-Gi3 serum was
purchased from Upstate Biotechnology (Lake Placid, NY).
35S-UTP and RNA labeling kits were
purchased from Amersham (Arlington Heights, IL).
32P- -ATP was purchased from ICN
Biochemicals (Costa Mesa, CA)
Autoradiographic studies
Preparation of brain sections
Male and female mice with intact (+/+), heterozygous (+/ ), and
homozygous knock-out ( / ) 5-HTT genes were decapitated. The whole
brains were removed and frozen immediately in dry, ice-cooled isopentyl
alcohol for 10 sec. Then the brains were placed on dry ice for 10 min
until they were frozen completely. Brains were stored at 80° C
until they were studied.
The mouse brain was cut into 15-µm-thick coronal sections in a
cryostat. The sections were thaw-mounted onto chromalum/gelatin-coated glass slides and stored at 80°C for studies within 1 month. Each slide contained brain sections from three mice (one genotype each) so
that we could limit variation between slides. Five levels of sections
were collected: frontal cortex (bregma 2.46-2.8 mm), striatum (bregma
0.98-0.50 mm), medial hypothalamus (bregma 0.7 to 1.06 mm), caudal
hypothalamus (bregma 1.34 to 1.94 mm), and midbrain (bregma 4.36
to 4.84 mm) according to a mouse brain atlas (Franklin and Paxinos,
1997 ). Adjacent sections were used in
125I-MPPI binding, in situ
hybridization, and 35S-GTP- -S binding studies.
Autoradiography of 125I-MPPI binding
125I-MPPI binding sites in the
brain sections were determined by autoradiographic assay as described
(Kung et al., 1995 ) with slight modification. Briefly, the slides were
thawed and dried in a desiccator at room temperature before assay. The
brain sections were preincubated for 30 min at room temperature in
assay buffer (50 mM Tris-HCl, pH 7.4, containing 2 mM MgCl2). Then the slides were
incubated with 125I-MPPI (0.14 nM in assay buffer) for 2 hr at room temperature. Nonspecific binding was defined in the presence of
10 5
M 5-HT. Then the slides were washed twice with assay buffer
at 4°C for 15 min and rinsed with cold ddH2O.
After being air blow-dried, the slides were exposed to
3H-Hyperfilm (Amersham) for 1 or 3 d.
The 125I-MPPI binding sites in the
hippocampus and dorsal raphe were measured by using films that were
exposed for 1 d. The remainders of the brain regions were analyzed
by using films exposed for 3 d. A set of
125I microscales (Amersham) was exposed
with the slides to calibrate the optic density into fmol/mg of tissue equivalent.
In situ hybridization for 5-HT1A mRNA
Preparation of riboprobes. A DNA fragment encoding
the third intracellular loop of mouse 5-HT1A
receptor (695-1110 bp) was inserted into PCRscript vector (Stratagene,
La Jolla, CA). After linearizing the plasmid with SacI or
KpnI for sense and antisense, respectively, we performed an
in vitro transcription with an RNA labeling kit (Amersham)
and 35S-UTP (1000 Ci/mmol, 20 mCi/ml;
Amersham). The template DNA was removed by incubating the RNase-free
DNase (10 U) at 37°C for 30 min. After the reaction was stopped by
adding 25 µl of STE (TE contains 150 mM NaCl,
pH 8.0), the 35S-labeled riboprobes were
purified by a ProbQuant G-50 micro column (Pharmacia, Piscataway, NJ).
Then the collected riboprobe (~50 µl) was precipitated by ethanol
(0.1 vol of 5 M ammonium acetate and 3 vol of
100% ethanol) and resuspended in 50 µl of DEPC-treated H2O after the pellets were washed with 75%
ethanol. Another riboprobe encoding the 3' noncoding region of
5-HT1A mRNA (1481-1860 bp) was prepared to
evaluate the selectivity of the probes.
Hybridization. Brain slides were thawed and dried as
described above. Then the brain sections were fixed by 4%
paraformaldehyde for 10 min. After being washed twice with PBS, the
sections were treated with 0.25% acetic anhydride in 1 M
triethanolamine for 10 min and dehydrated. After the sections were
air-dried, 150 µl of hybridization solution (20 mM Tris,
pH 7.4, 50% formamide, 0.3 M NaCl, 1 mM EDTA,
1× Denhardt's solution, 10% dextran sulfate, 150 mM DTT,
0.2% SDS, 50 µg/ml salmon sperm, 0.25 mg/ml tRNA, and 20,000-40,000
cpm/µl 35S-labeled probe) was added on
each slide, and the sections were covered with a coverslip. The slides
were incubated at 54°C overnight in humidified chambers (a plastic
box with two layers of filter paper wetted by 50% formamide in 2× SSC).
Then the slides were washed four times with 4× SSC for 5 min at room
temperature, followed by incubation of the slides with 40 µg/ml of
RNase A solution (0.01 M Tris, pH 8.0, 0.5 M
NaCl, and 1 mM EDTA) at 37°C for 30 min. After being
washed with 1, 0.5, and 0.1× SSC at room temperature for 5 min with
shaking, the slides were incubated four times in 0.1× SSC containing 2 mM DTT at 65°C for 15 min (DTT was added immediately
before incubation). Then the slides were incubated in 0.1× SSC and 2 mM DTT at room temperature for 1 min, followed by
dehydration with 50, 70, 90, and 95% ethanol containing 300 mM NH4Ac. After being rinsed with 100% ethanol, the slides were air-dried and exposed, along with a
14C-microscale (Amersham), to
3H-Hyper film for 7-14 d.
Autoradiography of 8-OH-DPAT-stimulated
35S-GTP- -S binding
8-OH-DPAT-stimulated 35S-GTP- -S
binding was performed as previously described (Sim et al., 1997 ; Waeber
and Moskowitz, 1997 ) with slight modification. Briefly, the brain
slides were thawed and dried in a desiccator for 1-2 hr (no more than
2 hr) at room temperature. After preincubation in the assay buffer
[containing (in mM) 50 Tris-HCl, pH 7.4, 3 MgCl2, 0.2 EGTA, 100 NaCl, and 0.2 DTT] for 15 min at room temperature, the slides were incubated in 2 mM
GDP (in assay buffer) for 15 min at room temperature. Then the slides
were incubated with 50 pM
35S-GTP- -S (in assay buffer containing
2 mM GDP) in the absence or presence of
10 5
M (+)8-OH-DPAT for 60 min at 30°C, defined as basal or
stimulated 35S-GTP- -S binding,
respectively. Nonspecific binding was defined in the presence of
10 5
M GTP- -S. The slides were washed twice in 50 mM Tris buffer, pH 7.4, for 3 min at 4°C. After being
rinsed with cold ddH2O, the slides were air-dried
and exposed to 3H-Hyperfilm film for 3-7
d. A14C microscale set was exposed
along with the slides to calibrate the density into fmol/mg of
tissue equivalent.
Data analysis
Brain images were captured and analyzed with the National
Institutes of Health Image program. The gray scale density readings were calibrated to fmol/mg of tissue equivalent by using the
microscales (125I microscale for
125I-MPPI binding and
14C microscale for in situ
hybridization and 35S-GTP- -S binding).
Brain regions were identified according to a mouse atlas (Franklin and
Paxinos, 1997 ). The adjacent brain sections were used for all three
autoradiographic studies. The data for a brain region of each mouse
represent the mean of four adjacent brain sections.
Specific 125I-MPPI binding in each brain
region was determined by subtracting the nonspecific binding sites from
the total binding sites in each region. 5-HT1A
mRNA levels in in situ hybridization were determined by
subtracting the hybridization of sense probe from that of antisense
probe. No difference was observed in the distribution and levels of
5-HT1A mRNA when in situ hybridization that used the probes encoding the third intracellular loop was compared
with that using the probes encoding the 3' noncodon region (data not shown).
8-OH-DPAT-stimulated 35S-GTP- -S binding
sites were determined by subtracting the basal
35S-GTP- -S binding (in the absence of
8-OH-DPAT) from the stimulated 35S-GTP- -S binding (in the presence of
8-OH-DPAT). Because a decrease either in the density of
5-HT1A receptors or in the G-protein coupling of
5-HT1A receptors would reduce the
8-OH-DPAT-stimulated 35S-GTP- -S binding
sites, the ratio of 125I-MPPI binding
sites and 8-OH-DPAT-stimulated
35S-GTP- -S binding sites was used to
express the G-protein coupling of 5-HT1A receptors.
Competitive RT-PCR for 5-HT1A receptors
Tissue preparation and total RNA isolation. Female
5-HTT +/+, +/ , and / mice (n = 8) were
decapitated, and the whole brain was removed from each. The
hypothalamus, hippocampus, and dorsal raphe regions were dissected. The
tissues were placed immediately in 1 ml of TriReagent (Sigma, St.
Louis, MO) at 4°C and homogenized with a Tissue Tearer homogenizer at
high speed for 10 sec in ice. The homogenates were stored at 80°C
until RNA isolation. Total RNA was isolated according to the protocol
of TriReagent and dissolved in 100 µl of DEPC-treated
H2O. The concentration of the RNA solution was
determined by absorbance at 260 nm. After treatment with DNase (Life
Technologies, Gaithersburg, MD), the RNA solutions then were
diluted to 10 ng/µl for dorsal raphe and 20 ng/µl for hypothalamus and hippocampus before use. The mRNA concentrations of the samples were
evaluated by RT-PCR of two housekeeping genes, cyclophilin and
glyceraldehyde-3-phosphate dehydrogenase (GPHAD). These genes were not
significantly different among the three genotypes of 5-HTT mutant mice
(data not shown).
Preparation of 5-HT1A standard. A
plasmid containing a DNA fragment encoding the third intracellular loop
of 5-HT1A receptor was digested by
PflMI. The resulting cohesive ends were excised by the
Klenow fragment of DNA polymerase. After religation the plasmid was
transfected into DH 10B Escherichia coli cells. A colony
with site mutation (four base pairs shorter than the original plasmid)
was selected and stored at 80°C.
To prepare 5-HT1A standard RNA, we
linearized the plasmid with SacI and transcripted it
with T7 RNA polymerase. After treatment with DNase the RNA was purified
by phenol/chloroform extraction, followed by ethanol precipitation. The
pellet was dissolved in DEPC-treated H2O. RNA
concentrations were determined by absorbance at 260 nm. A series of the
5-HT1A standard solutions was prepared by
sequential dilutions of the 5-HT1A standard RNA
stock solution.
Competitive RT-PCR. The competitive RT-PCR was modified from
the method described by Chun et al. (1996) . First-strand cDNA was
synthesized with the ThermoScript RT-PCR system (Life Technologies). Briefly, 5-HT1A standard RNA (1 µl) and total
RNA (1 µl) were incubated with a final concentration of 10 nM 5-HT1A primer
(5'-CAGTGTCTTCACTGTCTTCCT-3', which encoded mouse
5-HT1A antisense DNA 1110-1090 bp) at 65°C for
5 min in a total volume of 5 µl. Then the denatured RNA was incubated
with 5 µl of RT transcription master solution at 65°C for 45 min.
The reaction was terminated by incubation of the samples at 85°C for
5 min. Two microliters of the cDNA solution were used for subsequent
PCR. The PCR was performed in 10 µl of buffer solution containing 1×
PCR buffer, 1.5 mM MgCl2, 0.2 mM dNTP, 0.8 U platinum Taq DNA polymerase, 0.5 µM sense and antisense primers (sense, encoding
695-715 bp: TGCTCATGCGGTCCTCTAT; antisense, encoding 874-857 bp:
5'-TCTCAGCACTGCGCCTGC-3'), and the 5-HT1A cDNA.
After incubation at 94°C for 5 min, 28 cycles were performed at
denaturation, annealing, and extension of 94°C for 30 sec, 57°C for
30 sec, and 72°C for 30 sec, respectively. The reaction was
terminated by incubation at 72°C for 10 min and by the addition of 2 µl of loading dye. To visualize PCR products, we end-labeled the
antisense primer (2.5 µM) by incubating it with
32P-[ ]-ATP (ICN Biochemicals) and
T4 polynucleotide kinase (Epicentre">Epicenter Technologies,
Madison, WI) for 30 min at 37°C, followed by termination of the
reaction at 80°C for 5 min. The PCR products (2 µl) were resolved
on 8% polyacrylamide DNA sequencing gel (Sequagel-8, National
Diagnostics, Atlanta, GA). The gel was dried and exposed to Kodak
BioMax MR film. The films were analyzed densitometrically with the
National Institutes of Health Image analysis program. The gray scale
density was calibrated by a Control Scale T-14 (Kodak). The ratio
between the density of 5-HT1A mRNA and of
5-HT1A standard RNA was calculated. The logarithm
of the ratio was plotted with the logarithm of concentration of
5-HT1A standard RNA by using linear regression.
The x-axis intercept of the plot was calculated by a
computer program, Prism (Graphpad Software, San Diego, CA), to
determine the concentration of the 5-HT1A mRNA.
 |
Immunoblots |
The levels of Gi1,
Gi2, Gi3, and
Go proteins in the hypothalamus, midbrain, and
frontal cortex were measured by using immunoblots as described in our
previous paper with minor modification (Li et al., 1996 ). Briefly, the
solubilized proteins (10-35 µg of protein) that were extracted from
the membranes of the hypothalami, hippocampus, midbrains, and frontal
cortices (Sternweis and Robinshaw, 1984 ; Okuhara et al., 1996 ) were
resolved by SDS-polyacrylamide gel electrophoresis [containing 0.1%
sodium dodecyl sulfate (SDS), 12% acrylamide/bisacrylamide (30:0.2), 4 M urea, and 375 mM Tris, pH 8.4 (Mullaney and
Miligan, 1990 )]. Then the proteins were transferred electrophoretically to polyvinylidene difluoride (PVDF) membranes. The
membranes were incubated overnight with polyclonal antisera for
Gz (anti-Gz, 1:2500),
Gi1/2 (AS/7, 1:2500 dilution),
Gi3
(anti-Gi 3, 1:2000
dilution), or Go (anti-Go,
1:500 dilution), followed by a secondary antibody for 1 hr (1:25,000
goat anti-rabbit IgG-alkaline phosphatase). After several washes the
membranes were placed on a flat surface and incubated with a
chemiluminescence substrate solution, CDP-Star subtract (Tropix,
Bedford, MA), by pipetting a thin layer of the solution onto the
membranes (~3 ml/100 cm2)for 5 min. The
membranes were wrapped with Saran wrap and then exposed to Kodak x-ray
film for 5-30 sec. Films were analyzed densitometrically by the
National Institutes of Health Image analysis program as detailed in our
previous paper (Li et al., 1996 ).
Hypothermic response to a 5-HT1A agonist, 8-OH-DPAT in
female 5-HTT mutant mice
5-HTT +/+, +/ , and / mice were injected with 8-OH-DPAT
(0.1 mg/kg, s.c.). Body temperatures of the mice were measured every 10 min, from 20 min before to 60 min after the 8-OH-DPAT injections. The
means of the temperatures from 20 and 10 min before 8-OH-DPAT injections were used for the zero time point temperature measures. The
body temperatures of the mice were measured by a digital thermometer with a temperature probe (Physitemp BAT-12, Physitemp Instruments, Clifton, NJ) inserted 2-2.5 cm into the rectum, with the mice slightly
restrained by the tail. The temperatures were measured in a room with
an ambient temperature at 25°C.
 |
Statistics |
The data are presented as group means and the SEM of five
to eight mice. The data were analyzed by one-way or two-way ANOVA, followed by Student-Newman-Keuls post hoc tests when ANOVA
showed a significant difference. Statistics were performed with a
computer program (SuperANOVA, Abacus Concepts, Berkeley, CA).
 |
RESULTS |
Autoradiography of 125I-MPPI binding: The density of
5-HT1A receptors in 5-HTT mutant mice
125I-MPPI binding sites were reduced
significantly in the dorsal raphe of 5-HTT / mice
(Fig. 1;
Table 1). The reduction in the 5-HT1A receptors
was ~50% in the female and ~30% in the male mice (Table 1).
Although 5-HT1A receptors in the medial raphe were decreased significantly in the female 5-HTT mutant mice, a
significant reduction was not observed in the male mice (Table 1).

View larger version (153K):
[in this window]
[in a new window]
|
Figure 1.
Autoradiography of 125I-MPPI binding
in 5-HTT mutant mice. Left, Wild-type 5-HTT mice
(5-HTT +/+). Middle, Heterozygous 5-HTT
knock-out mice (5-HTT +/ ). Right,
Homozygous 5-HTT knock-out mice (5-HTT / ). The brain
sections from top to bottom are striatum
(bregma 0.98-0.50 mm), medium hypothalamus (bregma 0.7 to 1.06 mm),
caudal hypothalamus (bregma 1.34 to 1.94 mm), and midbrain (bregma
4.36 to 4.84 mm). ACo, Anterior cortical amygdaloid
nucleus; AH, anterior hypothalamic nucleus;
BLA, basolateral amygdaloid nucleus, anterior;
BMA, basomedial amygdaloid, anterior;
CA1-CA3, CA1-CA3 field of hippocampus;
CeC, central amygdaloid nucleus, capsular division;
CeMAD, central amygdaloid nucleus, medial anterodorsal;
CeMAV, central amygdaloid nucleus, medial anteroventral;
DEn, dorsal endopiriform nucleus; DG,
dentate gyrus of hippocampus; DMN, dorsomedial
hypothalamic nucleus; DRN, dorsal raphe nucleus;
La, lateral amygdaloid nucleus; Ld,
lambdoid septal zone; LH, lateral hypothalamic nucleus;
LSI, lateral septal nucleus, intermediate;
MeA, medial amygdaloid nucleus, anterodorsal;
MRN, medial raphe nucleus; MS, medial
septal nucleus; PVN, paraventricular hypothalamic
nucleus; VMN, ventromedial hypothalamic nucleus.
|
|
In the female 5-HTT knock-out mice the
125I-MPPI binding sites were reduced
significantly in all of the nuclei of the hypothalamus and several
nuclei in the amygdala and septum (Table 1). However, a similar
significant reduction was not observed in the male mice, although there
was a tendency toward reduction of the
125I-MPPI binding sites in these brain
regions, e.g., hypothalamus and amygdala (Table 1). In contrast, no
significant reduction in 125I-MPPI binding
sites was observed in the hippocampus and frontal cortex of either
female or male 5-HTT / mice (Table 1).
In situ hybridization to determine
5-HT1A mRNA in 5-HTT mutant mice
5-HT1A mRNA levels in the nuclei of raphe
and hypothalamus of 5-HTT mutant mice were examined by in
situ hybridization (Fig. 2; Table
2). The distribution of
5-HT1A mRNA was consistent with both riboprobes
(encoding the third intracellular loop or the 3' noncodon region),
suggesting that the riboprobe used in the assay was selective for
5-HT1A mRNA. 5-HT1A mRNA
levels were reduced significantly in the dorsal raphe of 5-HTT +/ and
/ male mice and 5-HTT / female mice (Table 2). No significant
change was observed in the other brain regions.

View larger version (157K):
[in this window]
[in a new window]
|
Figure 2.
Autoradiography of in situ
hybridization for 5-HT1A receptor mRNA in 5-HTT mutant
mice. The brain sections were hybridized with 32P-riboprobe
encoding the third intracellular loop, as described in Materials and
Methods. The brain sections were adjacent to the medial hypothalamus
and midbrain sections in the 125I-MPPI binding.
|
|
Competitive RT-PCR for examination of 5-HT1A mRNA in
5-HTT mutant mice
To confirm the results observed by in situ
hybridization, we conducted competitive RT-PCR to examine
5-HT1A mRNA in the hypothalamus, hippocampus, and
dorsal raphe regions. The plots of the competitive RT-PCR showed a high
linearity (Fig. 3). The mean of
regression coefficient (r2) was
0.96. The internal variation was 12.4%.

View larger version (28K):
[in this window]
[in a new window]
|
Figure 3.
An example of competitive RT-PCR for
5-HT1A receptor mRNA in the dorsal raphe of 5-HTT mutant
mice. A, Autoradiography of DNA sequence gel that
resolves RT-PCR products from 5-HT1A mRNA
(5-HT1A) and 5-HT1A RNA
standard (5-HT1A st). Four
concentrations of 5-HT1A RNA standard were used to compete
5-HT1A mRNA (10 ng of total RNA). B, Linear
regression curve for calculation of concentration of 5-HT1A
mRNA. The intercept of the x-axis represents the
concentration of 5-HT1A mRNA.
|
|
In competitive RT-PCR a significant reduction of
5-HT1A mRNA was observed in the dorsal raphe
region of female 5-HTT +/ and / mice (one-way ANOVA,
F(2, 18) = 5.1, p < 0.05; Table 3). This reduction was not
found in the hypothalamus or hippocampus (Table 3).
Autoradiography of 8-OH-DPAT-stimulated 35S-GTP- -S
binding in 5-HTT mutant mice
8-OH-DPAT increased 35S-GTP- -S
binding ~100% in the CA1 region of hippocampus and 50% in the
dorsal raphe (Figs. 4, 5). However, a
high basal level of 35S-GTP- -S binding
was observed in the hypothalamus and amygdala (Fig. 4), which caused a
limited increase of 35S-GTP- -S binding
in the presence of 8-OH-DPAT. Therefore, 8-OH-DPAT-stimulated 35S-GTP- -S binding sites were examined
only in the dorsal raphe and CA1 region of hippocampus.

View larger version (70K):
[in this window]
[in a new window]
|
Figure 4.
8-OH-DPAT-stimulated 35S-GTP- -S
binding in the hippocampus of normal mice. Top,
35S-GTP- -S binding in the presence of 8-OH-DPAT.
Middle, 35S-GTP- -S binding in the absence
of 8-OH-DPAT. Bottom, Nonspecific binding defined by the
presence of 10 5 M
GTP- -S.
|
|
8-OH-DPAT-stimulated 35S-GTP- -S binding
was reduced significantly in the dorsal raphe of 5-HTT / mice
(Table 4; Fig.
5). However, the ratio of
125I-MPPI binding sites and
8-OH-DPAT-stimulated 35S-GTP- -S binding
sites was not altered significantly in 5-HTT mutant mice (Table 4).
This suggested that the reduction of 8-OH-DPAT-stimulated 35S-GTP- -S binding in the dorsal
raphe is primarily attributable to the observed decreased density
of 5-HT1A receptors and not to a reduction in the
G-protein coupling of 5-HT1A receptors. On the
other hand, 8-OH-DPAT-stimulated
35S-GTP- -S binding was not changed in
the CA1 region of hippocampus of 5-HTT mutant mice (Table 4). No
difference in the basal level of
35S-GTP- -S was observed among three
genotypes of 5-HTT mutant mice.

View larger version (120K):
[in this window]
[in a new window]
|
Figure 5.
Autoradiography of 8-OH-DPAT-stimulated
35S-GTP- -S binding in the midbrain sections of 5-HTT
mutant mice. Left, 35S-GTP- -S binding in
the presence of 8-OH-DPAT. Right,
35S-GTP- -S binding in the absence of 8-OH-DPAT.
|
|
G-protein levels in brain of 5-HTT mutant mice
Several G-proteins that are coupled to
5-HT1A receptors were examined in the frontal
cortex, hypothalamus, hippocampus, and midbrain of female mice with
5-HTT mutations by using immunoblots (Fig.
6). Gi1 and
Go proteins in the midbrain of 5-HTT mice were reduced significantly as compared with their normal littermates. On the
other hand, Gz proteins in the hypothalamus were
increased significantly in 5-HTT / mice. No significant changes of
Gi2 and Gi3 proteins were
observed in any of the brain regions that were examined. None of the
G-proteins was altered in the hippocampus and frontal cortex (not shown
by data).

View larger version (36K):
[in this window]
[in a new window]
|
Figure 6.
G-protein concentrations in the midbrain
(top) and hypothalamus (bottom) of female
5-HTT mutant mice. The data represent the mean ± SEM of eight
mice per group. *Significant difference from 5-HTT +/+ mice;
p < 0.05.
|
|
Hypothermic response to 8-OH-DPAT in female 5-HTT mutant mice
The body temperature of 5-HTT +/+ mice was attenuated
significantly 10 min after injection with 8-OH-DPAT (Fig.
7). The peak time of the hypothermia that
was induced by 8-OH-DPAT was 20 min. The hypothermic response to
8-OH-DPAT was absent in 5-HTT / mice. Although there was a slight
attenuation of the body temperature after the injection with 8-OH-DPAT
in 5-HTT +/ mice, the difference did not reach statistical
significance when compared with 5-HT +/+ mice (Fig. 7). Furthermore,
there was no significant difference between the hypothermic response to
8-OH-DPAT in 5-HTT +/ and that in 5-HTT / mice.

View larger version (26K):
[in this window]
[in a new window]
|
Figure 7.
Hypothermic response to 8-OH-DPAT in female 5-HTT
knock-out mice. The data represent the mean ± SEM of 10 mice per
group. Two-way ANOVA: main effect of genotype,
F(2,147) = 31.07, p < 0.0001; main effect of time,
F(6,147) = 8.77, p < 0.0001; interaction between genotype and time,
F(12,147) = 1.49, p = 0.132. *Significant difference from those in the 0 time points of the
same genotype of 5-HTT, p < 0.05 (Student-Newman-Keuls' multiple range test). #, Significant
difference from the 5-HTT +/+ mice (at same time point),
p < 0.05 (Student-Newman-Keuls' multiple range
test).
|
|
 |
DISCUSSION |
The present studies demonstrated that the density of
5-HT1A receptors in 5-HTT / mice is reduced
in a brain region-specific manner. These results confirm our previous
observations that the desensitization of 5-HT1A
receptors in the hypothalamus and in the dorsal raphe nucleus of 5-HTT
mutant mice is mediated by a reduction of the density of
5-HT1A receptors (Li et al., 1999 ). Furthermore,
we have now shown that the reduction of 5-HT1A
receptors is more extensive in female than in male 5-HTT mutant mice.
This is consistent with the functional examination that the hypothermic response to 8-OH-DPAT is attenuated much more extensively in female than in male 5-HTT +/ mice. In our previous report male 5-HTT +/
mice demonstrated essentially no change in the hypothermic response to
8-OH-DPAT as compared with 5-HTT +/+ littermates (Li et al., 1999 ).
However, our present data indicated that this hypothermic response in
female 5-HTT +/ mice is virtually identical to 5-HTT / mice. The
reduction in the density of 5-HT1A receptors in the dorsal raphe of 5-HTT +/ and / mice may be, at least partly, attributable to a decrease in 5-HT1A gene
expression. On the other hand, no decrease in
5-HT1A receptor mRNA was observed in the hypothalamus of 5-HTT / mice. These results suggest that more than
one mechanism is involved in the regulation of the density of
5-HT1A receptors in different brain regions. In
addition, our studies of G-protein coupling to
5-HT1A receptors and G-protein levels indicated
that these elements in the 5-HT1A signal
transduction pathway do not play a major role in the desensitization of
5-HT1A receptors in the 5-HTT mutant mice.
Among different brain regions the most marked reduction of
5-HT1A receptors was observed in the dorsal raphe
nucleus of both male and female 5-HTT / mice. These data could
account for eliminated electrophysiological and hypothermic responses
to 8-OH-DPAT in 5-HTT / mice (Gobbi et al., 1999 ; Li et al., 1999 ),
functional tests for 5-HT1A receptors in the
dorsal raphe of mice (Bill et al., 1991 ). Also, these data are
consistent with the observations from other investigators who also
reported a reduction of 3H-WAY-100635 (a
5-HT1A antagonist) binding sites in the dorsal raphe nucleus, but not the CA1 region of hippocampus, in 5-HTT mutant
mice (Fabre et al., 1998 ). Besides the dorsal raphe, a reduction in the
density of 5-HT1A receptors also was demonstrated in the median raphe, most nuclei of hypothalamus, as well as some nuclei of the amygdala and septum of female 5-HTT / mice. Although the density of 5-HT1A receptors in the nuclei of
hypothalamus of male 5-HTT / mice was not statistically different,
a tendency toward a reduction was observed in all of the hypothalamic
nuclei. In fact, a homogenate ligand-binding assay showed that the
density of 5-HT1A receptors was reduced
significantly in the hypothalamus of male 5-HTT knock-out mice (Li et
al., 1999 ). It has been known that the hypothalamus and amygdala are
related to the regulation of emotion. It is possible that the reduction
in the 5-HT1A receptors in these regions
contributes to the increase of anxiety and decrease in depression-like
behaviors that recently were observed in the 5-HTT / mice (C. Wichems, unpublished data). On the other hand, no significant changes
of 5-HT1A receptors have been found in the
hippocampus and frontal cortex.
All together, these results suggest that 5-HT1A
receptors in 5-HTT mutant mice are regulated differently in the
different brain regions. In the dorsal raphe of 5-HTT mutant mice the
5-HT1A receptors are reduced extensively, which
might be attributable to a decrease in gene expression, i.e.,
regulation of gene transcription. On the other hand, the density, but
not mRNA, of 5-HT1A receptors is reduced in the
hypothalamus, amygdala, septum, and median raphe of 5-HTT mutant mice,
suggesting that translational regulation and/or post-translational
modifications may be involved. The mechanism underlying the regulation
of 5-HT1A receptors in the different brain
regions of 5-HTT mutant mice is still unknown.
5-HT1A receptors in the dorsal and median raphe
nuclei are autoreceptors. The reduction in the density of
5-HT1A receptors could result from a feedback regulation induced by sustained high extracellular concentrations of
5-HT because of the lack of the 5-HTT (Mathews et al., 2000 ). The fact
that the reduction of the 5-HT1A receptors in the
dorsal raphe is more extensive than in other brain regions supports the hypothesis that the 5-HT1A autoreceptors are more
sensitive to an increase of 5-HT than postsynaptic
5-HT1A receptors (Artigas et al., 1996 ; Blier et
al., 1998 ).
An important finding in the present studies is that the reduction of
5-HT1A receptors is substantially greater in the
female than in the male 5-HTT mutant mice. Furthermore, in comparison to our previous results in male mice (Li et al., 1999 ), the hypothermic response to 8-OH-DPAT in female 5-HTT +/ mice is more marked than
that in male 5-HTT mutant mice. This result is important because it may
provide an insight into why women more frequently develop affective and
some anxiety disorders. It has been known that female gonadal hormones,
especially estrogen, can regulate 5-HT1A
receptors (Lakoski, 1989 ; Maswood et al., 1995 ; Trevino et al., 1999 ;
Osterlund et al., 2000 ). For example, estrogen treatment attenuated
5-HT1A receptor functions (Lakoski, 1989 ; Maswood
et al., 1995 ) and decreased 5-HT1A receptor mRNA
levels in ovariectomized monkey and rats (Pecins-Thompson and Bethea,
1999 ; Osterlund et al., 2000 ). On the other hand, estrogen also reduces
5-HTT mRNA concentrations (Pecins-Thompson et al., 1998 ). Therefore,
the remarkable decrease of the 5-HT1A receptors
in female 5-HTT mutant mice could result from synergistic effects of
estrogen and the 5-HTT mutation on 5-HT1A
receptors and/or interaction between estrogen and 5-HTT.
Another possible cause for the desensitization of
5-HT1A receptors is alteration of their G-protein
coupling. Although 8-OH-DPAT-stimulated GTP- -S binding in the dorsal
raphe was reduced significantly in the 5-HTT / mice, the ratio of
125I MPPI and 8-OH-DPAT-stimulated
GTP- -S binding was not altered significantly. This suggests that the
reduction in the 8-OH-DPAT-stimulated GTP- -S binding is attributable
to a decrease of the number of 5-HT1A receptors,
but not any attenuation of G-protein coupling to
5-HT1A receptors. Furthermore, although
Go and Gi1 proteins in the
midbrain are reduced significantly, but modestly, in the female 5-HTT
/ mice, these and other G-proteins in the hypothalamus, hippocampus, and frontal cortex were not reduced significantly. It is
interesting that Gz proteins in the hypothalamus
are increased even modestly in the 5-HTT mutant mice.
Gz proteins are coupled to
5-HT1A receptors in the hypothalamus that
regulate oxytocin release (Serres et al., 2000 ). The elevation of the
Gz proteins in the 5-HTT mutant mice could be a
compensatory effect for reduction in the 5-HT1A
receptors in the hypothalamus. All together, these data suggest that
alteration in the G-protein coupling to the 5-HT1A receptors is not a major mechanism for the
desensitization of 5-HT1A receptors in 5-HTT
mutant mice.
Similar to these findings in 5-HTT mutant mice, the desensitization of
5-HT1A receptors also has been observed after
chronic administration of SSRIs in human and rodents (Li et al., 1997a ; Lerer et al., 1999 ; Raap et al., 1999 ). In both situations the desensitization of 5-HT1A receptors occurs in the
hypothalamus and dorsal raphe, but not in the hippocampus and cortex
(Le Poul et al., 1995 , 2000 ; Li et al., 1997a ). However, the mechanisms underlying the desensitization may be different between 5-HTT mutant
mice and that found after chronic treatment with SSRIs. In 5-HTT mutant
mice the density of 5-HT1A receptors, but not their signal transduction, is reduced. On the other hand, chronic treatment with SSRIs does not reduce the density of
5-HT1A receptors in any brain regions (Li et al.,
1997b ; Le Poul et al., 2000 ). Instead, some decreases in several
G-protein concentrations have been observed (Li et al., 1996 , 1997a ).
These differences may be attributable to the much longer and more
marked lack or reduction of 5-HTT function in the 5-HTT mutant mice
than that in the SSRI-treated animals. An alternative explanation could
be that the reduction of 5-HT1A receptors in
5-HTT mutant mice results from more complex changes during neuron development.
In conclusion, the present studies demonstrate that
5-HT1A receptors in the 5-HTT mutant mice are
brain region-specifically reduced. This result could account for our
previous results indicating that 5-HT1A
receptor-mediated temperature and neuroendocrine responses are
desensitized in 5-HTT mutant mice ((Li et al., 1999 ). The reduction in
the density of 5-HT1A receptors in the dorsal
raphe, but not in hypothalamus, may be attributable to an attenuation of 5-HT1A gene expression. More interestingly,
the reduction of 5-HT1A receptors is more
extensive in the female than in the male 5-HTT mutant mice. This is
consistent with our finding that female 5-HTT mutant mice have a more
prominent and consistent increase in anxiety than males when compared
with their normal littermates. The significance of these observations
is that it may provide a greater insight for the frequently reported
higher incidence of affective and some anxiety disorders in women and
also the premenstrual syndrome symptomatology.
 |
FOOTNOTES |
Received June 8, 2000; revised Aug. 8, 2000; accepted Aug. 14, 2000.
We thank Dr. Barry B. Kaplan and Dr. Jayaprakash D. Karkera for their
excellent advice and Teresa Tolliver and Su-Jan Huang for their
important technical assistance with these experiments.
Correspondence should be addressed to Dr. Qian Li, Laboratory of
Clinical Science, National Institute of Mental Health, National Institutes of Health Clinical Center, Room 3D41, 10 Center Drive, MSC
1264, Bethesda, MD 20892-1264. E-mail: qianli{at}codon.nih.gov.
 |
REFERENCES |
-
Artigas F,
Romero L,
De Montigny C,
Blier P
(1996)
Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.
Trends Neurosci
19:378-383[Web of Science][Medline].
-
Bengel D,
Murphy DL,
Andrews AM,
Wichems CH,
Feltner D,
Heils A,
Mossner R,
Westphal H,
Lesch KP
(1998)
Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine ("ecstasy") in serotonin transporter-deficient mice.
Mol Pharmacol
53:649-655[Abstract/Free Full Text].
-
Bill DJ,
Knight M,
Forster EA,
Fletcher A
(1991)
Direct evidence for an important species-difference in the mechanism of 8-OH-DPAT-induced hypothermia.
Br J Pharmacol
103:1857-1864[Web of Science][Medline].
-
Blier P,
Pineyro G,
El Mansari M,
Bergeron R,
De Montigny C
(1998)
Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission.
Ann NY Acad Sci
861:204-216[Web of Science][Medline].
-
Chun JT,
Gioio AE,
Crispino M,
Giuditta A,
Kaplan BB
(1996)
Differential compartmentalization of mRNAs in squid giant axon.
J Neurochem
67:1806-1812[Web of Science][Medline].
-
Fabre V,
Rioux A,
Lanfumey L,
Lesch K-P,
Hamon M
(1998)
Adaptive changes in central 5-HT receptors in knock-out mice lacking the 5-HT transporter.
Soc Neurosci Abstr
24:1113.
-
Franklin KBJ,
Paxinos G
(1997)
In: The mouse brain in stereotaxic coordinates. San Diego: Academic.
-
Gobbi G,
Lesch KP,
Murphy DL,
Blier P
(1999)
The serotonin transporter knock-out mice: new perspectives on the comprehension of serotonin system.
Soc Neurosci Abstr
25:714.
-
Greenberg BD,
Li Q,
Lucas FR,
Hu S,
Sirota LA,
Benjamin J,
Lesch KP,
Hamer D,
Murphy DL
(2000)
Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample.
Am J Med Genet
96:202-216[Web of Science][Medline].
-
Heisler LK,
Chu HM,
Brennan TJ,
Danao JA,
Bajwa P,
Parsons LH,
Tecott LH
(1998)
Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice.
Proc Natl Acad Sci USA
95:15049-15054[Abstract/Free Full Text].
-
Kung M-P,
Frederick D,
Mu M,
Zhuang Z-P,
Kung HF
(1995)
4-(2'-Methoxy-phenyl)-1-[2'-(n-2"-pyridinyl)-p-iodobenzamido]-ethyl-piperazine ([125I]p-MPPI) as a new selective radioligand of serotonin-1A sites in rat brain: in vitro binding and autoradiographic studies.
J Pharmacol Exp Ther
272:429-437[Abstract/Free Full Text].
-
Lakoski JM
(1989)
Cellular electrophysiological approaches to the central regulation of female reproductive aging.
In: Neurology and neurobiology, Vol 50, Neural control of reproductive function (Lakoski JM,
Perez-Polo JR,
Rassin DK,
eds), pp 209-220. New York: Liss.
-
Le Poul E,
Laaris N,
Doucet E,
Laporte AM,
Hamon M,
Lanfumey L
(1995)
Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine.
Naunyn Schmiedebergs Arch Pharmacol
352:141-148[Web of Science][Medline].
-
Le Poul E,
Boni C,
Hanoun N,
Laporte AM,
Laaris N,
Chauveau J,
Hamon M,
Lanfumey L
(2000)
Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine.
Neuropharmacology
39:110-122[Web of Science][Medline].
-
Lerer B,
Gelfin Y,
Gorfine M,
Allolio B,
Lesch KP,
Newman ME
(1999)
5-HT1A receptor function in normal subjects on clinical doses of fluoxetine: blunted temperature and hormone responses to ipsapirone challenge.
Neuropsychopharmacology
20:628-639[Web of Science][Medline].
-
Lesch KP,
Bengel D,
Heils A,
Sabol SZ,
Greenberg BD,
Petri S,
Benjamin J,
Muller CR,
Hamer DH,
Murphy DL
(1996)
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region.
Science
274:1527-1531[Abstract/Free Full Text].
-
Li Q,
Muma NA,
Van de Kar LD
(1996)
Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain Gi and Go proteins and in neuroendocrine responses to a 5-HT1A agonist.
J Pharmacol Exp Ther
279:1035-1042[Abstract/Free Full Text].
-
Li Q,
Muma NA,
Battaglia G,
Van de Kar LD
(1997a)
A desensitization of hypothalamic 5-HT1A receptors by repeated injections of paroxetine: reduction in the levels of Gi and Go proteins and neuroendocrine responses, but not in the density of 5-HT1A receptors.
J Pharmacol Exp Ther
282:1581-1590[Abstract/Free Full Text].
-
Li Q,
Battaglia G,
Van de Kar LD
(1997b)
Autoradiographic evidence for differential G-protein coupling of 5-HT1A receptors in rat brain: lack of effect of repeated injections of fluoxetine.
Brain Res
769:141-151[Web of Science][Medline].
-
Li Q,
Wichems C,
Heils A,
Van de Kar LD,
Lesch KP,
Murphy DL
(1999)
Reduction of 5-hydroxytryptamine (5-HT1A)-mediated temperature and neuroendocrine responses and 5-HT1A binding sites in 5-HT transporter knock-out mice.
J Pharmacol Exp Ther
291:999-1007[Abstract/Free Full Text].
-
MacKenzie A,
Quinn J
(1999)
A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo.
Proc Natl Acad Sci USA
96:15251-15255[Abstract/Free Full Text].
-
Maswood S,
Stewart G,
Uphouse L
(1995)
Gender and estrous cycle effects of the 5-HT1A agonist, 8-OH-DPAT, on hypothalamic serotonin.
Pharmacol Biochem Behav
51:807-813[Web of Science][Medline].
-
Mathews TA,
Fedele DE,
Unger EL,
Lesch K-P,
Murphy DL,
Andrews AM
(2000)
Effects of serotonin transporter inactivation on extracellular 5-HT levels, in vivo microdialysis recovery, and MDMA-induced release of serotonin and dopamine in mouse striatum.
Soc Neurosci Abstr
26:11599.
-
Mazzanti CM,
Lappalainen J,
Long JC,
Bengel D,
Naukkarinen H,
Eggert M,
Virkkunen M,
Linnoila M,
Goldman D
(1998)
Role of the serotonin transporter promoter polymorphism in anxiety-related traits.
Arch Gen Psychiatry
55:936-940[Abstract/Free Full Text].
-
Mullaney I,
Miligan G
(1990)
Identification of two distinct isoforms of the guanine nucleotide binding protein Go in neuroblastoma X glioma hybrid cells: independent regulation during cyclic AMP-induced differentiation.
J Neurochem
55:1890-1898[Web of Science][Medline].
-
Murphy DL,
Wichems C,
Li Q,
Heils A
(1999)
Molecular manipulations as tools for enhancing our understanding of 5-HT neurotransmission.
Trends Pharmacol Sci
20:246-252[Medline].
-
Okuhara DY,
Lee JM,
Beck SG,
Muma NA
(1996)
Differential immunohistochemical labeling of Gs, Gi1 and 2, and Go
-subunits in rat forebrain.
Synapse
23:246-257[Web of Science][Medline]. -
Osterlund MK,
Halldin C,
Hurd YL
(2000)
Effects of chronic 17
-estradiol treatment on the serotonin 5-HT1A receptor mRNA and binding levels in the rat brain.
Synapse
35:39-44[Web of Science][Medline]. -
Parks CL,
Robinson PS,
Sibille E,
Shenk T,
Toth M
(1998)
Increased anxiety of mice lacking the serotonin-1A receptor.
Proc Natl Acad Sci USA
95:10734-10739[Abstract/Free Full Text].
-
Pecins-Thompson M,
Bethea CL
(1999)
Ovarian steroid regulation of serotonin-1A autoreceptor messenger RNA expression in the dorsal raphe of rhesus macaques.
Neuroscience
89:267-277[Web of Science][Medline].
-
Pecins-Thompson M,
Brown NA,
Bethea CL
(1998)
Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques.
Mol Brain Res
53:120-129[Medline].
-
Raap DK,
Evans S,
Garcia F,
Li Q,
Muma NA,
Wolf WA,
Battaglia G,
Van de Kar LD
(1999)
Daily injections of fluoxetine induce dose-dependent desensitization of hypothalamic 5-HT1A receptors: reductions in neuroendocrine responses to 8-OH-DPAT and in levels of Gz and Gi proteins.
J Pharmacol Exp Ther
288:98-106[Abstract/Free Full Text].
-
Ramboz S,
Oosting R,
Amara DA,
Kung HF,
Blier P,
Mendelsohn M,
Mann JJ,
Brunner D,
Hen R
(1998)
Serotonin receptor 1A knock-out: an animal model of anxiety-related disorder.
Proc Natl Acad Sci USA
95:14476-14481[Abstract/Free Full Text].
-
Serres F,
Li Q,
Garcia F,
Raap DK,
Battaglia G,
Muma NA,
Van de Kar LD
(2000)
Evidence that Gz proteins couple to hypothalamic 5-HT1A receptors in vivo.
J Neurosci
20:3095-3103[Abstract/Free Full Text].
-
Sim LJ,
Xiao RY,
Childers SR
(1997)
In vitro autoradiographic localization of 5-HT1A receptor-activated G-proteins in the rat brain.
Brain Res Bull
44:39-45[Web of Science][Medline].
-
Sternweis PC,
Robinshaw JD
(1984)
Isolation of two proteins with high affinity for guanine nucleotides from membranes of bovine brain.
J Biol Chem
259:13806-13813[Abstract/Free Full Text].
-
Stoltenberg SF,
Burmeister M
(2000)
Recent progress in psychiatric genetics
some hope but no hype.
Hum Mol Genet
9:927-935[Abstract/Free Full Text]. -
Trevino A,
Wolf A,
Jackson A,
Price T,
Uphouse L
(1999)
Reduced efficacy of 8-OH-DPAT's inhibition of lordosis behavior by prior estrogen treatment.
Horm Behav
35:215-223[Medline].
-
Waeber C,
Moskowitz MA
(1997)
5-Hydroxytryptamine (1A) and 5-hydroxytryptamine (1B) receptors stimulate [35S]guanosine-5'-O-(3-thio)triphosphate binding to rodent brain sections as visualized by in vitro autoradiography.
Mol Pharmacol
52:623-631[Abstract/Free Full Text].
-
Zhou FC,
Tao-Cheng JH,
Segu L,
Patel T,
Wang Y
(1998)
Serotonin transporters are located on the axons beyond the synaptic junctions: anatomical and functional evidence.
Brain Res
805:241-254[Web of Science][Medline].
-
Zhuang XX,
Gross C,
Santarelli L,
Compan V,
Trillat AC,
Hen R
(1999)
Altered emotional states in knock-out mice lacking 5-HT1A or 5-HT1B receptors.
Neuropsychopharmacology
21:S52-S60.
Copyright © 2000 Society for Neuroscience 0270-6474/00/20217888-08$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
L. N. Cornelisse, J. E. Van der Harst, J. C. Lodder, P.J.J. Baarendse, A. J. Timmerman, H. D. Mansvelder, B. M. Spruijt, and A. B. Brussaard
Reduced 5-HT1A- and GABAB Receptor Function in Dorsal Raphe Neurons Upon Chronic Fluoxetine Treatment of Socially Stressed Rats
J Neurophysiol,
July 1, 2007;
98(1):
196 - 204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Neumeister, X.-Z. Hu, D. A. Luckenbaugh, M. Schwarz, A. C. Nugent, O. Bonne, P. Herscovitch, D. Goldman, W. C. Drevets, and D. S. Charney
Differential Effects of 5-HTTLPR Genotypes on the Behavioral and Neural Responses to Tryptophan Depletion in Patients With Major Depression and Controls.
Arch Gen Psychiatry,
September 1, 2006;
63(9):
978 - 986.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Alexandre, D. Popa, V. Fabre, S. Bouali, P. Venault, K.-P. Lesch, M. Hamon, and J. Adrien
Early life blockade of 5-hydroxytryptamine 1A receptors normalizes sleep and depression-like behavior in adult knock-out mice lacking the serotonin transporter.
J. Neurosci.,
May 17, 2006;
26(20):
5554 - 5564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. David, N. V. Murthy, E. A. Rabiner, M. R. Munafo, E. C. Johnstone, R. Jacob, R. T. Walton, and P. M. Grasby
A Functional Genetic Variation of the Serotonin (5-HT) Transporter Affects 5-HT1A Receptor Binding in Humans
J. Neurosci.,
March 9, 2005;
25(10):
2586 - 2590.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Li, A. Holmes, L. Ma, L. D. Van de Kar, F. Garcia, and D. L. Murphy
Medial Hypothalamic 5-Hydroxytryptamine (5-HT)1A Receptors Regulate Neuroendocrine Responses to Stress and Exploratory Locomotor Activity: Application of Recombinant Adenovirus Containing 5-HT1A Sequences
J. Neurosci.,
December 1, 2004;
24(48):
10868 - 10877.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Camilleri
Is there a SERT-ain association with IBS?
Gut,
October 1, 2004;
53(10):
1396 - 1399.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Barr, T. K. Newman, M. Schwandt, C. Shannon, R. L. Dvoskin, S. G. Lindell, J. Taubman, B. Thompson, M. Champoux, K. P. Lesch, et al.
Sexual dichotomy of an interaction between early adversity and the serotonin transporter gene promoter variant in rhesus macaques
PNAS,
August 17, 2004;
101(33):
12358 - 12363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. El Yacoubi, S. Bouali, D. Popa, L. Naudon, I. Leroux-Nicollet, M. Hamon, J. Costentin, J. Adrien, and J.-M. Vaugeois
Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression
PNAS,
May 13, 2003;
100(10):
6227 - 6232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. A. Tjurmina, I. Armando, J. M. Saavedra, D. S. Goldstein, and D. L. Murphy
Exaggerated Adrenomedullary Response to Immobilization in Mice with Targeted Disruption of the Serotonin Transporter Gene
Endocrinology,
December 1, 2002;
143(12):
4520 - 4526.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Riad, K. C. Watkins, E. Doucet, M. Hamon, and L. Descarries
Agonist-Induced Internalization of Serotonin-1A Receptors in the Dorsal Raphe Nucleus (Autoreceptors) But Not Hippocampus (Heteroreceptors)
J. Neurosci.,
November 1, 2001;
21(21):
8378 - 8386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Ranganathan, E. R. Sawin, C. Trent, and H. R. Horvitz
Mutations in the Caenorhabditis elegans Serotonin Reuptake Transporter MOD-5 Reveal Serotonin-Dependent and -Independent Activities of Fluoxetine
J. Neurosci.,
August 15, 2001;
21(16):
5871 - 5884.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|